Pacira Pharmaceuticals, Inc. 4
4 · Pacira Pharmaceuticals, Inc. · Filed Jun 12, 2013
Insider Transaction Report
Form 4
Pratt John
General Manager, San Diego
Transactions
- Sale
Common Stock
2013-06-10$30.00/sh−5,398$161,940→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2013-06-11−12,945→ 131,657 totalExercise: $10.81Exp: 2022-06-04→ Common Stock (12,945 underlying) - Exercise/Conversion
Common Stock
2013-06-10$10.81/sh+5,398$58,352→ 5,398 total - Exercise/Conversion
Common Stock
2013-06-11$10.81/sh+12,945$139,935→ 12,945 total - Exercise/Conversion
Employee Stock Option (right to buy)
2013-06-10−5,398→ 144,602 totalExercise: $10.81Exp: 2022-06-04→ Common Stock (5,398 underlying) - Sale
Common Stock
2013-06-11$30.00/sh−12,945$388,350→ 0 total
Footnotes (1)
- [F1]The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vests and becomes exercisable as to the remaining shares in successive equal monthly installments for the subsequent 36 months.